Literature DB >> 10418894

Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older.

P O Honkanen1, T Keistinen, L Miettinen, E Herva, U Sankilampi, E Läärä, M Leinonen, S L Kivelä, P H Mäkelä.   

Abstract

The effectiveness of simultaneously administered influenza and pneumococcal vaccines vs. influenza vaccine alone in preventing pneumonia, pneumococcal pneumonia and pneumococcal bacteraemia among the elderly was studied. The vaccines were offered to all persons aged 65 years or older (N=43,500) living in 35 administrative districts in Northern Finland. A total of 26,925 persons (62%) decided to participate. Allocation to the vaccination groups took place by year of birth (odd/even). The total follow-up of those vaccinated consisted of 38,037 person years. The incremental effectiveness of the pneumococcal vaccine was -20 (95% CI -50- + 10%) for pneumonia, -20 (95% CI -90- + 20%) for pneumococcal pneumonia and + 60% (95% CI -40- +90%) for pneumococcal bacteraemia. Thus the pneumococcal polysaccharide vaccine did not offer any additional protection from pneumonia among elderly people in Finland although it reduced the incidence of bacteraemia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10418894     DOI: 10.1016/s0264-410x(99)00069-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  27 in total

1.  Cluster randomised controlled trial of an educational outreach visit to improve influenza and pneumococcal immunisation rates in primary care.

Authors:  A Niroshan Siriwardena; Aly Rashid; Mark R D Johnson; Michael E Dewey
Journal:  Br J Gen Pract       Date:  2002-09       Impact factor: 5.386

2.  The controversy over the efficacy of pneumococcal vaccine.

Authors:  Ross Andrews; Sarah A Moberley
Journal:  CMAJ       Date:  2009-01-06       Impact factor: 8.262

3.  Pneumococcal Vaccination in Adults.

Authors:  Tsering Y Sherpa; Howard L Leaf
Journal:  Curr Infect Dis Rep       Date:  2005-05       Impact factor: 3.725

Review 4.  Pneumococcal disease in the elderly: what is preventing vaccine efficacy?

Authors:  J B Rubins; E N Janoff
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 5.  [Pneumococcal vaccine effectiveness in the elderly. Systematic review and meta-analysis].

Authors:  J Puig-Barberà; A Belenguer Varea; M Goterris Pinto; M J Brines Benlliure
Journal:  Aten Primaria       Date:  2002-09-30       Impact factor: 1.137

Review 6.  Vaccines for preventing pneumococcal infection in adults.

Authors:  Sarah Moberley; John Holden; David Paul Tatham; Ross M Andrews
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

Review 7.  Advances in pneumococcal vaccines: what are the advantages for the elderly?

Authors:  Angel Vila-Córcoles
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

8.  Pneumococcal vaccination in older adults induces antibodies with low opsonic capacity and reduced antibody potency.

Authors:  Jeremy G Schenkein; Saeyoung Park; Moon H Nahm
Journal:  Vaccine       Date:  2008-08-13       Impact factor: 3.641

9.  Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study.

Authors:  Angela Domínguez; Núria Soldevila; Diana Toledo; Pere Godoy; Núria Torner; Luis Force; Jesús Castilla; José María Mayoral; Sonia Tamames; Vicente Martín; Mikel Egurrola; Francisco Sanz; Jenaro Astray
Journal:  Hum Vaccin Immunother       Date:  2016-04-11       Impact factor: 3.452

Review 10.  Pneumococcal vaccines for children and adults with bronchiectasis.

Authors:  Christina C Chang; Rosalyn J Singleton; Peter S Morris; Anne B Chang
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.